GMED R&D to Revenue
Globus Medical, Inc. Class A Common Stock · R&D to Revenue
GMED R&D to Revenue
Latest reported6.29%period ending
GMED FY R&D/Revenue (8.07% → 6.29%)
Latest values, visible window
High-resolution chart · PNG
GMED r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 6.2949% | |
| 6.4998% | |
| 7.9064% | |
| 7.1384% | |
| 10.1603% | |
| 10.7116% | |
| 7.649% | |
| 7.7838% | |
| 6.868% | |
| 7.8958% | |
| 6.6658% | |
| 6.57% | |
| 6.1847% | |
| 7.2348% | |
| 7.0786% | |
| 7.394% | |
| 8.0682% |